Serotonin syndrome due to fluoxetine and tramadol in renal impaired patient
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 1)Publication Date: 2014-02-01
Authors : Rajnish Raj Raj Kumar Balwant Singh Sidhu Saurabh Yakhami;
Page : 227-229
Keywords : Serotonin syndrome; SSRIs (Serotonin Reuptake Inhibitors); Opioids; Drug-drug interactions; CYP 450;
Abstract
Serotonin syndrome causes confusion or altered mental status; other symptoms include myoclonus, shivering, tremors, diaphoresis, hyperreflexia, incoordination, fever and diarrhoea. Tramadol possesses dual pharmacological effects i.e., a weak opiate agonist at mu, kappa and delta opiate receptors along with reuptake inhibition of norepinephrine and serotonin. Risk associated with tramadol increases when co-administered with serotonergic antidepressants or MAOIs (monoamine oxidase inhibitors) and in renal impaired. The incidence of this syndrome is less than 1% as most of the cases remain unreported. The case highlights the fact that interaction between serotonergic agents like fluoxetine and tramadol especially in the presence of co-morbid medical illness can lead to serotonin syndrome. [Int J Basic Clin Pharmacol 2014; 3(1.000): 227-229]
Other Latest Articles
- Clindamycin as trigger of uroporphyrinuria
- Psychosocial and medical factors affecting treatment compliance in patients attending psychiatric hospital: a study from Kashmir
- Potentially inappropriate medications in hospitalised elderly patients: a cross sectional study
- Nonsteroidal anti-inflammatory drug (NSAID) associated fixed drug eruption (FDE) in children attending dermatology OPD of a tertiary care hospital of Eastern India: a cross-sectional observational study
- Vitamin D supplementation attenuated carageenan-induced paw edema and formalin-induced nociception in indomethacin-treated rats
Last modified: 2014-02-08 13:51:08